Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation

[1]  M. Kasten,et al.  Regulatory functions of Cdk9 and of cyclin T1 in HIV Tat transactivation pathway gene expression , 1999, Journal of cellular biochemistry.

[2]  A. Giordano,et al.  The CDK9-associated cyclins T1 and T2 exert opposite effects on HIV-1 Tat activity. , 1999, AIDS.

[3]  A. Giordano,et al.  Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo , 1999, Oncogene.

[4]  R. Watson,et al.  B‐Myb protein in cellular proliferation, transcription control, and cancer: Latest developments , 1999, Journal of cellular physiology.

[5]  Pasquale De Luca,et al.  B-MYB transactivates its own promoter through SP1-binding sites , 1999, Oncogene.

[6]  A. Giordano,et al.  Binding of CDK9 to TRAF2 , 1998, Journal of cellular biochemistry.

[7]  A. Giordano,et al.  CDK9 (PITALRE): A multifunctional cdc2‐related kinase , 1998, Journal of cellular physiology.

[8]  A. Giordano,et al.  Cloning of murine CDK9/PITALRE and its tissue‐specific expression in development , 1998, Journal of cellular physiology.

[9]  J. Milton,et al.  Identification of multiple cyclin subunits of human P-TEFb. , 1998, Genes & development.

[10]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[11]  A. Giordano,et al.  Retinoblastoma‐related protein pRb2/p130 and its binding to the B‐myb promoter increase during human neuroblastoma differentiation , 1997, Journal of cellular biochemistry.

[12]  A. Rice,et al.  TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Giordano,et al.  CDC2‐related kinase PITALRE phosphorylates pRb exclusively on serine and is widely expressed in human tissues , 1997, Journal of cellular physiology.

[14]  R. Watson,et al.  B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation , 1997, Oncogene.

[15]  K. Klempnauer,et al.  Phosphorylation and activation of B-Myb by cyclin A–Cdk2 , 1997, Current Biology.

[16]  C. Peschle,et al.  Activation of human B-MYB by cyclins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Bishop,et al.  myb provides an essential function during Drosophila development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Peschle,et al.  The Retinoblastoma Family Member p107 Binds to B-MYB and Suppresses Its Autoregulatory Activity* , 1996, The Journal of Biological Chemistry.

[19]  M. Dahmus.  Reversible Phosphorylation of the C-terminal Domain of RNA Polymerase II* , 1996, The Journal of Biological Chemistry.

[20]  B. Calabretta,et al.  Requirement of B- myb Function for Survival and Differentiative Potential of Human Neuroblastoma Cells (*) , 1995, The Journal of Biological Chemistry.

[21]  R. Aebersold,et al.  A brain-specific activator of cyclin-dependent kinase 5 , 1994, Nature.

[22]  L. Tsai,et al.  p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 , 1994, Nature.

[23]  A. Giordano,et al.  PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  E. Lam,et al.  An E2F‐binding site mediates cell‐cycle regulated repression of mouse B‐myb transcription. , 1993, The EMBO journal.

[25]  E. Lam,et al.  Transcription regulation by murine B-myb is distinct from that by c-myb. , 1993, Nucleic acids research.

[26]  T. Bouwmeester,et al.  Molecular cloning, expression and in vitro functional characterization of Myb-related proteins in Xenopus , 1992, Mechanisms of Development.

[27]  B. Calabretta,et al.  Growth regulated expression of B‐MYB in fibroblasts and hematopoietic cells , 1991, Journal of cellular physiology.

[28]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[29]  N. Nomura,et al.  Isolation of human cDNA clones of myb-related genes, A-myb and B-myb. , 1988, Nucleic acids research.

[30]  A. E. Sippel,et al.  The highly conserved amino‐terminal region of the protein encoded by the v‐myb oncogene functions as a DNA‐binding domain. , 1987, The EMBO journal.

[31]  T. Gonda,et al.  Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia , 1984, Nature.

[32]  A. Levinson,et al.  The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb , 1983, Cell.

[33]  J. Bishop,et al.  Structure and transcription of the cellular homolog (c-myb) of the avian myeloblastosis virus transforming gene (v-myb) , 1983, Journal of virology.

[34]  B. Reid.  A nucleic Acid. , 1979, Science.

[35]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Saville,et al.  B-Myb: a key regulator of the cell cycle. , 1998, Advances in cancer research.

[37]  R. Watson,et al.  The role of Myb proteins in normal and neoplastic cell proliferation. , 1994, Critical reviews in oncogenesis.